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ABSTRACT 
 
Propolis is a natural resinous hive product collected by honeybees from exudates of 
plant sources. It has been used in folk medicine due to its various chemical compounds 
with biological properties since ancient times. The aim of this study was to compare the 
chemical constituents and to evaluate the in-vitro cytotoxicity and hemolytic activity of 
Indian propolis against human breast cancer (MCF 7), colon cancer (HCT 116), and 
prostate cancer (PC 3) cell lines by MTT assay.  The propolis extracts were incubated 
with cancer cell lines for 24 hours, cytotoxicity was measured colorimetrically and the 
IC50 value was calculated. Propolis samples were analyzed by GC-MS and 44 
compounds were identified. The results indicated that inspite of the differences in the 
chemical composition of propolis collected from different geographic locations all the 
samples exhibited significant cytotoxic activity and did not affect normal cells. It is 
concluded that the Indian propolis is a potential natural source of chemopreventive 
agent.  
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INTRODUCTION 
 
Cancer can be regarded as a group of 
diseases characterized by an abnormal 
growth of cells. Cancer may occur in any type 
of cells or tissues of the body and 
approximately 11 million people are diagnosed 
with cancer and more than 6 million die from 
this disease every year1.  The epidemiological 
findings strongly suggest that the cancer rates 
are the highest in affluent societies mainly due 
to lifestyle issues. Nearly 180,000 women are 
diagnosed every year with breast cancer in 
North America2.  Mortality rates of cancer 
have increased during the past 60 years in 
every country, especially in developed 
countries and becoming more frequent in 
developing countries as well3.  According to 
International agency for research on cancer, it 
is estimated that cancer is a major health 
problem in India. They have reported that 
about 555,000 people have died of cancer in 
20104.  It is reported that the incidence of 
breast cancer is rising rapidly in India as a 
result of changes in reproductive risk factors, 
dietary habits and increasing life 
expectancy5.Therefore, there is a need to 
develop mechanism based approach for 
management of cancer, besides the present 
major treatment modalities which may include 
surgery, medication, radiotherapy, and 
immunotherapy. Chemoprevention is one of 
the most promising upcoming modality in 
oncology research which focuses on 
prevention of cancer using naturally occurring 
or synthetic agents which inhibit, delay, or 
reverse carcinogenesis6. The National Cancer 
Institute, United States, routinely measures 
the growth inhibitory properties of 
chemopreventive drugs against human tumor 
cell lines. Propolis, a resinous sticky 
substance collected from plants by honeybees 
is one of the richest sources of phenols and 
phenolic compounds, which are widely 
recognized as chemopreventive compounds7-
8. The phenolic compounds display a wide 
range of pharmacological properties including 
antimicrobial, anti-inflammatory, anti-diabetic, 
antioxidant, hepatoprotective and cytostatic 
activity9. These bioactive compounds vary 
based on the geographical location and floral 
diversity. This has led to an increasing 
emphasis on cancer prevention strategies in 
which propolis is used as dietary supplement 
being the richest source of plant phenolic 
compounds. Several in-vitro studies of 
propolis in  human cancers involving 
mechanisms like inhibition of cell cycle 
progression, cell proliferation, tumor growth 
arrest, prevention of metastasis, and 
apoptosis has been frequently reported in 
literature10-15.  The present study was carried 
out to evaluate the Propolis properties of Apis 
mellifera collected from different parts of India 
by determining the in-vitro cytotoxicity using 
some cancer cell lines, such as breast cancer 
(MCF 7) cell lines, colon cancer (HCT 116) 
cell lines and prostate cancer (PC 3) cell lines 
with hemolytic activity.  The chemical 
compositions were analyzed using GC-MS. 
The comparative study of biological properties 
of Propolis from the different geographic 
locations with different chemical composition 
is the most interesting trend in recent Propolis 
research16. There are very few studies on the 
chemical composition of Indian Propolis and 
its application in human health care.  
 
MATERIALS AND METHODS 
 
The Propolis samples were collected from 
different locations in India like Karnal from 
Haryana, (K [HA]), Dehradun from Uttarkand 
(D [UK]), Coimbatore from Tamil Nadu (C 
[TN]) and Bijapur from Karnataka (B [KA]) 
States of India, during January- March 2014.  
 
(i) Preparation of ethanol extract of 
Propolis 
The Propolis extract was prepared by mixing 5 
grams of each Propolis sample with 50 ml of 
70% ethanol and extracted at room 
temperature. The 70% ethanol used is a semi 
polar solvent which can extract all active 
components with different polarity in the 
propolis17. The ethanol extract was 
evaporated under vacuum till dryness. The 
extractive value (extracted matter) was 
recorded as 24.6% of K [HA] sample, 30.4% 
from D [UK] Propolis sample, 29.8% of C [TN] 
Propolis sample and 31.2% from B [KA] 
Propolis. The resulting extracts obtained used 
for the GC-MS analysis and determination of 
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cytotoxic effects on different human cancer 
cell lines. 
  
(ii) GC-MS Analysis 
The propolis samples were analyzed in GC-
MS Clarus 500 (Perkin Elmer) instrument 
equipped with Restek RtxR – 5 (30 m X 0.25 
mm and 0.25µm of film thickness) column and 
flow rate of Helium as mobile phase was set to 
0.7mL/min.  In gas chromatography, the oven 
temperature initially was programmed at 40oC 
for 5 minutes, then rise to 200oC at a rate of 
6oC/min and finally holds at 280oC for 1 hour.  
 
(iii) Cell culture    
Cancer cell lines were obtained from 
American type culture collection centre, United 
States. The stock culture of these cell lines 
were cultured in Dulbecco’s modified eagle’s 
medium supplemented with 10% FBS and 1% 
Streptomycin.  The cells were incubated at 
37°C with 5% CO2 in a humidified atmosphere 
and the confluent cells were sub cultured with 
0.25% trypsin and the cells were suspended in 
DMEM (MCF 7) and RPMI (HCT 116 and PC 
3) media.   
 
(iv)Determination of cytotoxicity of 
propolis  
The cytotoxicity of propolis extracts were 
tested by quantitative colorimetric MTT 
assay18.  The cells were plated into 96-well 
plates and incubated at 37°C in 5% CO2 
incubator for 24 hours. After incubation, each 
concentration of propolis extract (5-320µg/mL) 
was added. The plates were incubated at 
37°C in 5% CO2 incubator for 24 hours.  Later, 
MTT solution (100µL/well) was added and 
incubated for 3-4 hours. Finally, the blue 
formazan crystal was dissolved with 100 µL of 
Dimethyl Sulfoxide and absorbance was 
measured at 590 nm.  The percentage of 
inhibition was calculated comparing with the 
cell control. The median inhibitory 
concentration (IC50) values were determined. 
 
(v)  Hemolytic assay 
This method is based on the release of 
hemoglobin which can be measured by 
spectrophotometer and is suited to evaluate 
the haemocompatibility of biomaterial on Red 
Blood Cells (RBCs).   Blood was collected 
from healthy human beings and centrifuged at 
1000 rpm for 10 minutes at 4oC.  Plasma was 
removed and erythrocyte was washed thrice 
with PBS (pH 7.4). Propolis extract of different 
concentrations (5, 10,20,40,80,160 and 
320µg/mL) was added to erythrocyte 
suspension and incubated at 37°C for 1 hr. 
Later, the volume was adjusted to 1mL with 
PBS, centrifuged at 300 rpm for 3 minutes and 
hemoglobin concentration was measured by 
means of a spectrophotometer at 540 nm19. 
Propolis samples were compared with 
reference material (1% SDS) to evaluate 
hemolytic activity.  
 
RESULTS AND DISCUSSION 
 
The propolis extracts were subjected to GC-
MS analysis, the most often used technique 
for chemical analysis and the total separated 
peaks are shown in Figure 1-4. The 
chromatograms of all major peaks were 
matched with National Institute Standard and 
Technology (NIST) database for identification 
of chemical compounds present in the sample. 
The compounds that belong to different 
chemical groups were identified in each 
propolis samples. According to GC-MS 
analysis, it is concluded that the four propolis 
samples showed qualitative similarities in 18 
compounds like Oxalic Acid, Propanoic acid,  
Formaldehyde oxime trimer, Hydrazine,  
Hydroxyethylhydrazine,  Hydroxypropanoic 
acid , 1,2-Ethanedio,  Methylglyoxal,  
Butanone,  Acetic acid,   Propanedioic acid,  
Methanecarbothiolic acid , 1 Pentene 2 
methyl, 1-Hexene,  (3-Methyl-oxiran-2-yl)-
methanol,  Cyclopropane,  Cyclohexane, 
Cyclopentane methyl and  2 amino-oxazole. 
According to the difference in plant sources, 
each propolis sample is characterized by 
certain specific compounds. Sample K [HA] is 
the only sample containing Cyclobutane, 2 
Azetidinone and Boranamine.  Sample D [UK] 
was characterized by the presence of the 
compounds like   Formic acid, Methanamine 
and Butanenitrile.  Sample C [TN] was 
characterized by the presence of Hydrogen 
azide and Sample B[KA] was characterized by 
the presence of o-Methylisourea hydrogen 
sulfate,  1-Nitro-á-d-arabinofuranose, 
tetraacetate, Tetraacetyl-d-xylonic nitrile, 14-
Oxa-1,11- 
diazatetracyclo[7.4.1.0(2,7).0(10,12)]tetradeca
-2,4,6-triene, 11-acetyl-6,9-bis (acetyloxy) -4-
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formyl-8-[(aminocarbonyloxy)methyl],  O-
Methylisourea,  2,6-dibromo-4-(4-
morpholinylthiocarbonyl) phenyl ester, N,N-
[Dimethyl]-N'-methyl-N'-[2-[2-naphthalenyl]-6-
trichloromethylpyrimidin-4-ylethylenediamine,  
Bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(á-D-
glucopyranosyloxy)-8,14-dihydroxyl, 1,2,4-
Triazino[5,6-E][1,2,4]-triazine-3,6-dione,  
Pregan-20-one, 2-hydroxy-5,6-epoxy-15-
methyl and  Diacetyl sulphide  are new to 
propolis. Isopropyl Alcohol present in samples  
B[KA] and K[HA], 1,2,4,5-Tetroxane, 3,3,6,6-
tetramethyl  is present in samples B[KA] and 
C[TN],  Methyltartronic acid  has been present 
in samples C[TN] and D[UK] and (3-Methyl-
oxiran-2-yl)-methanol  has been characterized 
in samples K[HA] and D[UK]. In the present 
study, 3 cancer cell lines (MCF 7, HCT 116, 
and PC 3) were treated with 4 propolis 
extracts at various concentrations ranged from 
5-320µg/mL for 24 hours in vitro. The cell 
viability was evaluated by colorimetric MTT 
assay, which depends on the reduction of 
MTT [3-(4,5- dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] by mitochondria 
of living cells to form  blue formazan product20  
According to the result, the cell line MCF 7 
inhibition was observed maximum in B [KA] 
and K [HA] with IC50 value 26.88µg/mL and 
43.47µg/mL  compared to C [TN] and D [UK], 
with  IC50 values were 66.53µg/mL and 
104µg/mL respectively. The similar result has 
been observed in cell line HCT116, where the 
highest induced cytotoxicity in B[KA] and 
K[HA] with IC50 value 75.33µg/mL and 
90.47µg/mL  whereas C[TN] and D[UK] 
resulted the IC50 value of 93.72µg/mL and 
101.40µg/mL.  In cell line PC3, B [KA] 
exhibited pronounced cytotoxic effect 
(41.80µg/mL) while IC50 of propolis from C 
[TN], K [HA] and D [UK] were 63.86µg/mL, 
65.50µg/mL and 134.5µg/mL respectively 
(Table 1). The hemolytic activity of crude 
propolis extracts was performed by 
spectroscopic method at different 
concentrations (5, 10, 20, 40, 80,160 and 
320µg/mL) using fresh human blood sample. 
Based on the result, all the studied samples 
showed very less toxic effect on human RBCs 
(< 10% hemolysis) at different dilutions 
(Figure 5).  The tested propolis can be 
considered as safe to human erythrocytes. 
Hemolytic activity is a requirement to be 
tested for any blood contacting medical device 
where the interactions between blood and 
biomaterials may induce lysis of erythrocytes, 
particularly during prolonged contact or during 
contact of blood with large surfaces. Since 
many cancer drugs used presently may cause 
adverse side effects by being cytotoxic to 
normal cells, hence it is necessary to find new 
compounds that will not cause any adverse 
side effects of being cytotoxic to normal cells.  
 
 
                                  
Figure 1 
GC- MS Chromatogram of K [HA] 
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Figure 2 
GC- MS Chromatogram of D [UK] 
                 
 
                                 
Figure 3 
GC- MS Chromatogram of C [TN] 
 
Int J Pharm Bio Sci 2014 Oct; 5(4): (P) 698 - 706 
 
 
This article can be downloaded from www.ijpbs.net 
P - 703 
 
                                   
Figure 4 
GC- MS Chromatogram of B [KA] 
 
Table 1 
Percentage of cytotoxicity and IC50 value of Indian propolis 
 extracts on MCF 7, HCT116 and PC 3 cell lines 
 
Samples 
 Conc.     
 µg/mL 
%  Inhibition 
     MCF 7 
%  Inhibition 
   HCT 116 
%  Inhibition 
     PC 3 
Control 1% DMSO 0.00 0.00 0.00 
          
C[TN] 
5 1.07 0.53 2.40 
10 4.28 3.83 8.65 
20 15.10 12.66 18.98 
40 30.49 22.16 34.94 
80 45.29 36.15 62.90 
160 60.98 59.96 74.51 
320 72.89 65.96 90.04 
IC50    66.53µg/mL  93.72µg/mL  93.86µg/mL  
K[HA] 
5 1.70 1.98 3.47 
10 8.23 4.49 8.07 
20 17.94 19.39 24.24 
40 39.54 26.39 38.61 
80 51.98 44.66 54.55 
160 67.39 57.19 66.12 
320 74.48 75.99 88.23 
IC50    43.47µg/mL  90.47µg/mL  90.47µg/mL  
B[KA] 
5 9.56 5.94 2.90 
10 17.77 13.03 7.76 
20 36.04 19.66 16.63 
40 51.90 34.56 45.29 
80 67.29 51.32 61.65 
160 73.37 66.09 77.52 
320 85.10 79.82 82.22 
IC50    26.88µg/mL  75.33µg/mL  41.80µg/mL  
D[UK] 
5 2.51 2.90 0.36 
10 7.90 8.44 6.38 
20 14.22 16.62 12.32 
40 25.47 28.36 22.09 
80 46.61 39.58 48.39 
160 61.17 63.59 63.67 
320 78.49 74.08 87.13 
   IC50   104µg/mL  101.40µg/mL  134.50µg/mL 
                                             Note:  C [TN]- Coimbatore [Tamil Nadu],  K[HA]-Karnal [Haryana],  B[KA]- Bijapur  
                                             [Karnataka], D[UK]-Dehradun [Uttarkand] 
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Figure 5 
Percentage of hemolytic activity from the different concentrations 
(5, 10,20,40,80,160 &320µg/mL) of propolis extracts on Human RBCs 
 
 
 
 
According to MTT cytotoxic assay, all propolis 
samples showed cytotoxicity against the 
examined cell lines, but the percent of 
inhibition varied depending on propolis origin. 
It was noted that propolis collected from 
Bijapur show the highest cytotoxic activity 
against HCF 7, HCT 116 and PC 3, but 
propolis collected from Coimbatore and Karnal 
had moderate activity against all tested cell 
lines. Propolis collected from Dehradun 
exhibited lower cytotoxicity when compared 
with propolis collected from other regions. The 
variation in cytotoxic activity seems to be due 
to the differences in the chemical composition 
of different propolis samples. The higher 
cytotoxicity was demonstrated by Bijapur 
propolis, probably attributed to the presence of 
some compounds such as  o-Methylisourea 
hydrogen sulfate, 1-Nitro-á-d-arabinofuranose, 
tetraacetate,  Tetraacetyl-d-xylonic nitrile,  14-
Oxa-1,11-
diazatetracyclo[7.4.1.0(2,7).0(10,12)]tetradeca
-2,4,6-triene, 11-acetyl-6,9-bis(acetyloxy)-4-
formyl-8-[(aminocarbonyloxy)methyl],  O-
Methylisourea,  2,6-dibromo-4-(4-
morpholinylthiocarbonyl) phenyl ester, N,N-
[Dimethyl]-N'-methyl-N'-[2-[2-naphthalenyl]-6-
trichloromethylpyrimidin-4-ylethylenediamine,  
Bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(á-D-
glucopyranosyloxy)-8,14-dihydroxyl, 1,2,4-
Triazino[5,6-E][1,2,4]-triazine-3,6-dione and  
Pregan-20-one, 2-hydroxy-5,6-epoxy-15-
methyl as per our investigation by GC-MS. 
The chemical composition of these propolis 
samples indicated that they are a potential 
source of naturally occurring bioactive 
compounds with biological and 
pharmacological applications. Several authors 
have studied chemical content of some Indian 
propolis 21-23. but still there is a need to study 
the detailed chemical constituents of propolis 
from different ecological zones of India. Kartal 
et al., (2003)24 has provided comprehensive 
report on the use of propolis to treat several 
human diseases.  The chemical composition 
and their bioactivity vary depending on 
geographical and botanical origin 25-27. The 
ethanolic extract of Brazilian propolis showed 
potent cytotoxicity against prostate cancer cell 
line28.  The ethyl acetate extract of Indonesian 
propolis induced sufficiently strong cytotoxicity 
on MCF 7 with IC50 47.45µg/mL, similarly the 
ethanolic extract of Trigona spp. from 
Indonesia induced 81.43% of cytotoxicity on 
human breast cancer cell lines 29-30 which 
support the present result. The significant 
anticancerous activity of propolis is due to the 
presence of phenolic compounds and its 
ability to induce cytotoxicity at low 
concentration against carcinoma cell lines 
besides safeguarding normal cells even at 
high concentration 31.  
 
CONCLUSION 
 
The present findings suggest that the 
ethanolic extract of propolis indicated it is the 
most effective and promising inhibition of 
human breast cancer, colon cancer, and 
prostate cancer cell lines. These effects are 
attributed to the chemical composition of 
propolis, which is highly dependent on the 
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geographical location of the flora. The GC-MS 
analysis of these 4 samples showed the 
presence of 44 compounds which was 
identified by comparing of their mass spectra 
with the NIST library data and literature. The 
identification of chemical compounds present 
in propolis is   extremely valuable and 
promising with respect to standardization and 
practical applications in therapy.  The present 
study opens up a new perspective for future 
research in cancer science through in- vivo 
evaluation of Indian Propolis. 
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